PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Unidad de Revisiones Sistemáticas y Meta-análisis (URSIGET), Vicerrectorado de Investigación, Universidad San Ignacio de Loyola (USIL), Lima, Peru.\', \'Hospital Guillermo Kaelin de La Fuente, Lima, Peru.\', \'Department of Internal Medicine, Henry Ford Hospital, Detroit, Michigan, United States of America.\', \'Escuela de Medicina, Universidad Peruana de Ciencias Aplicadas (UPC), Lima, Peru.\', \'MedErgy Health Group Inc. Yardley, Pennsylvania, United States of America.\', \'Health Outcomes, Policy, and Evidence Synthesis (HOPES) Group, University of Connecticut School of Pharmacy, Storrs, Connecticut, United States of America.\', \'Department of Research Administration, Hartford Hospital. Hartford, Connecticut, United States of America.\', \'Hemex Health Inc. Portland, Oregon, United States of America.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1371/journal.pone.0243705
?:doi
?:hasPublicationType
?:journal
  • PloS one
is ?:pmid of
?:pmid
?:pmid
  • 33301514
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.164
?:rankingScore_hIndex
  • 241
?:title
  • Efficacy and harms of remdesivir for the treatment of COVID-19: A systematic review and meta-analysis.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33301514>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33301514>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all